JSW
CLX icon

Journey Strategic Wealth’s Clorox CLX Stock Holding History

Journey Strategic Wealth’s Portfolio CLX Stock Details CLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$411K Buy
3,968
+616
+18% +$69.8K 0.01% 405
2025
Q4 		$338K Sell
3,352
-443
-12% -$48.1K 0.01% 457
2025
Q3 		$468K Sell
3,795
-20
-0.5% -$2.48K 0.01% 317
2025
Q2 		$458K Buy
3,815
+805
+27% +$107K 0.01% 311
2025
Q1 		$443K Buy
3,010
+64
+2% +$9.77K 0.02% 250
2024
Q4 		$478K Buy
2,946
+3
+0.1% +$491 0.02% 225
2024
Q3 		$479K Buy
2,943
+14
+0.5% +$2.08K 0.02% 222
2024
Q2 		$400K Buy
2,929
+247
+9% +$34.3K 0.02% 197
2024
Q1 		$411K Hold
2,682
– – 0.02% 148
2023
Q4 		$382K Hold
2,682
– – 0.02% 113
2023
Q3 		$352K Hold
2,682
– – 0.02% 102
2023
Q2 		$427K Sell
2,682
-465
-15% -$75K 0.02% 95
2023
Q1 		$498K Sell
3,147
-64
-2% -$9.6K 0.05% 103
2022
Q4 		$451K Sell
3,211
-45
-1% -$6.39K 0.05% 106
2022
Q3 		$417K Buy
3,256
+192
+6% +$27.7K 0.06% 78
2022
Q2 		$432K Sell
3,064
-30
-1% -$4.29K 0.06% 66
2022
Q1 		$430K Sell
3,094
-66
-2% -$10.1K 0.05% 64
2021
Q4 		$551K Buy
+3,160
New +$527K 0.06% 65

Other funds holding CLX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Journey Strategic Wealth's CLX Position: Q1 2026 in Review

Journey Strategic Wealth increased its Clorox (CLX) stake by 18% in Q1 2026, buying an estimated $69.8K and bringing the position to 3,968 shares worth $411K. The position accounts for 0.01% of the portfolio, ranked #405.

Journey Strategic Wealth first reported a position in CLX in Q4 2021 and has held it in 18 quarters since. The position peaked at $551K in Q4 2021. 1,080 funds tracked by Wall St. Rank hold CLX as of Q1 2026.

  • Journey Strategic Wealth held 3,968 shares of Clorox worth $411K as of Q1 2026.
  • Journey Strategic Wealth bought 616 Clorox shares in Q1 2026, an estimated $69.8K.
  • Clorox made up 0.01% of Journey Strategic Wealth's portfolio in Q1 2026, its #405 holding.
  • Journey Strategic Wealth first reported a position in Clorox in Q4 2021 and has held it in 18 quarters since.
  • Journey Strategic Wealth's Clorox position peaked at $551K in Q4 2021.
  • 1,080 funds tracked by Wall St. Rank held Clorox as of Q1 2026.

Based on Journey Strategic Wealth's 13F filing for Q1 2026, filed 15 Apr 2026.